The President of IRBM who produced the Ebola vaccine in 2014: “Procedures already started”.
IRBM, Pomezia (Italy) and the Jenner Institute of Oxford University strengthen their long-lasting collaboration by announcing a new agreement aimed to develop a vaccine for the novel coronavirus.
Pietro Di Lorenzo, President and CEO of IRBM, is moderately optimistic given the experience of both the Jenner Institute and his Company. He confirms that animal testing will start by summer, while human testing could begin in autumn. Of course, if the pandemic keeps growing, the time of reactions to face this emergency will be strongly shorten by all the subjects involved, including institutions, who have always been responsive towards national security crisis.
Article published on Il Giornale – 08/02/2020